The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence

Peer Review reports

Original Submission
27 Oct 2019	Submitted	Original manuscript
26 Nov 2019	Reviewed	Reviewer Report - Simone Baldovino
10 Feb 2020	Reviewed	Reviewer Report - Salah Ghabri
30 Mar 2020	Author responded	Author comments - Gerlienke Voerman
Resubmission - Version 2
30 Mar 2020	Submitted	Manuscript version 2
Publishing
2 Apr 2020	Editorially accepted
28 Jul 2020	Article published	10.1186/s41927-020-00130-x

Back to article page